Royalindo Investa Wijaya Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Royalindo Investa Wijaya Tbk. trades at Rp184 (market cap 819.98B, 35.04M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Royalindo Investa Wijaya Tbk. is far larger — about 4.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Royalindo Investa Wijaya Tbk. is more actively traded (35.04M versus 324K). Which is the better fit depends on your goals.
| INDO | OBAT | |
|---|---|---|
Market Cap | 819.98B | 166.01B |
Volume | 35.04M | 324K |
Lot | 350.41K | 3.24K |
Turnover | 6.39B | 77.68M |
Average Price | 182.46 | 239.75 |
Value | 6.39B | 77.68M |
Indicative Equilibrium Price | 184 | 240 |
Indicative Equilibrium Volume | 15 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Royalindo Investa Wijaya Tbk (the Company) was established based on Notarial Deed No. 19 dated July 6, 2005 of Tse Min Suhardi, S.H., a public notary in Jakarta. The Company started its commercial operations in July 6, 2005.
Read more on INDO →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →